Saudi Central Bank boosted its position in Amrize Ltd (NYSE:AMRZ – Free Report) by 89.6% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 34,844 shares of the company’s stock after buying an additional 16,471 shares during the period. Saudi Central Bank’s holdings in Amrize were worth $1,857,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in AMRZ. MCF Advisors LLC bought a new position in Amrize during the 4th quarter worth $27,000. Basepoint Wealth LLC bought a new stake in shares of Amrize in the fourth quarter valued at about $33,000. US Bancorp DE bought a new stake in shares of Amrize in the third quarter valued at about $38,000. Itau Unibanco Holding S.A. grew its stake in shares of Amrize by 150.0% in the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock valued at $41,000 after acquiring an additional 450 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its stake in shares of Amrize by 141.3% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 847 shares of the company’s stock valued at $46,000 after acquiring an additional 496 shares in the last quarter.
Insider Buying and Selling
In other news, insider Mario Gross acquired 3,568 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The shares were acquired at an average cost of $46.60 per share, with a total value of $166,268.80. Following the completion of the purchase, the insider directly owned 38,485 shares of the company’s stock, valued at $1,793,401. The trade was a 10.22% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jacques Sanche acquired 4,150 shares of the firm’s stock in a transaction that occurred on Wednesday, August 26th. The stock was purchased at an average cost of $45.02 per share, for a total transaction of $186,833.00. Following the completion of the purchase, the director directly owned 9,766 shares of the company’s stock, valued at $439,665.32. The trade was a 73.90% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders acquired 48,983 shares of company stock worth $2,158,755. 0.54% of the stock is owned by company insiders.
Amrize Stock Up 0.0%
Amrize (NYSE:AMRZ – Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a return on equity of 10.22% and a net margin of 9.89%.The firm had revenue of $3.49 billion for the quarter. Sell-side analysts forecast that Amrize Ltd will post 2.72 earnings per share for the current fiscal year.
Amrize Dividend Announcement
The company also recently announced a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were given a $0.11 dividend. The ex-dividend date was Tuesday, August 18th. Amrize’s payout ratio is presently 20.28%.
Wall Street Analysts Forecast Growth
Several analysts have weighed in on the stock. Royal Bank Of Canada cut shares of Amrize from a “sector perform” rating to an “underperform” rating and dropped their price objective for the stock from $60.00 to $48.00 in a research note on Monday, August 10th. Oppenheimer decreased their target price on shares of Amrize from $68.00 to $65.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 21st. Bank of America reaffirmed an “underperform” rating and set a $40.00 target price (down from $50.00) on shares of Amrize in a report on Wednesday, September 2nd. Sanford C. Bernstein reiterated an “outperform” rating on shares of Amrize in a research report on Monday, June 22nd. Finally, Zacks Research cut Amrize from a “hold” rating to a “strong sell” rating in a research note on Wednesday, August 19th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $56.38.
Get Our Latest Stock Analysis on AMRZ
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
See Also
- Five stocks we like better than Amrize
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
